NEW YORK (GenomeWeb) – Weill Cornell Medicine announced today that it has received a $5 million gift to launch a new initiative that will accelerate and expand its use of precision medicine in patient care.

The gift was made by investment firm WorldQuant and its founder Igor Tulchinsky to support the creation of the WorldQuant Initiative for Quantitative Prediction, which aims to develop and use predictive tools and quantitative methods to better understand the genetic factors that drive disease in individual patients.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.